Risk Assessment For Benefits Analysis: Framework for Analysis of A Thyroid-Disrupting Chemical

By Axelrad Daniel   Baetcke Karl   Dockins Chris   Griffiths Charles   Hill Richard   Murphy Patricia   Owens Nicole   Simon Nathalie   Teuschler Linda  

Journal of Toxicology and Environmental Health, Vol. 68, Iss. 11-12, 2005-06 ,pp. : 837-855

Taylor & Francis Ltd

Access to resources Recommend Favorite

Analysis of PM2.5 Using the Environmental Benefits Mapping and Analysis Program (BenMAP)

By Davidson Kenneth   Hallberg Aaron   McCubbin Donald   Hubbell Bryan  

Journal of Toxicology and Environmental Health, Vol. 70, Iss. 3-4, 2007-01 ,pp. : 332-346

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Efficacy of Acamprosate and Naltrexone in the Treatment of Alcohol Dependence: A Relative Benefits Analysis of Randomized Controlled Trials

By Snyder James   Bowers Thomas  

The American Journal of Drug and Alcohol Abuse, Vol. 34, Iss. 4, 2008-07 ,pp. : 449-461

Informa Healthcare

Access to resources Recommend Favorite

Clinical Benefits with Oseltamivir in Treating Influenza in Adult Populations: Results of a Pooled and Subgroup Analysis

By Singh S.  

Clinical Drug Investigation, Vol. 23, Iss. 9, 2003-01 ,pp. : 561-569

Adis International

Access to resources Recommend Favorite

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

By Peterson Kim   McDonagh Marian   Fu Rongwei  

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite